BBlogFlow

Phil Collins reveals how daughter Lily Collins 'burst into tears' discussing his health struggles with family - HELLO! Magazine

·Oct 4, 2026
Source: HELLO! Magazine
Read the original article

This story deserves to be shared

Send it to someone who'd care, or post it on your networks.

Facebook Twitter Email

Phil Collins is opening up in an extensive new interview about his struggles with his career, his struggles with his health and the toll it has had on his family. The English singer, 75, has been open about his struggles with alcoholism in the past, especially in the wake of his third divorce, which most recently resulted in him being hospitalized for seven months in 2023 due to damage to his kidneys.© Getty ImagesPhil Collins opened up about the impact of his health struggles on his familyHis family members have been open about the difficult period, most notably his daughter Lily Collins, who even penned an open letter to her father concerning his absence during her childhood. Phil Collins' holiday family reunionWhile the pair were distant during her early years, the 37-year-old actress and her musician father have since reconciled and are now closer than ever. In fact, during an October 2 appearance on Piers Morgan Uncensored, the former Genesis member opened up about his deepening relationship with his children now.

This article is an excerpt. To read the full content, visit the original source. HELLO! Magazine

Reactions

0 comments

No comments yet. Be the first to share your thoughts!

Facebook Twitter

Related articles

Continuous glucose monitors help type 2 diabetes patients spend 5 more hours a day in healthy blood sugar range - Medical Xpress

Continuous glucose monitors (CGMs) could transform diabetes management for millions of Americans with type 2 diabetes who don't take insulin, according to findings published in the New England Journal of Medicine. The clinical trial found that adults using CGMs spent approximately five additional hours each day within their target blood sugar range compared with those receiving routine care. Nearly twice as many CGM users also achieved an A1c level below 7%, a common treatment goal for people with diabetes.

Medical Xpress·

Kefah Mokbel: Can Whole-Genome Sequencing-Based ctDNA Monitoring Help Personalize Adjuvant Treatment? - Oncodaily

“Beyond Detecting Cancer Recurrence: Can Whole-Genome Sequencing-Based ctDNA Monitoring Help Personalize Adjuvant Treatment? An exciting new study published in The Oncologist highlights the clinical potential of Signatera Genome, a whole-genome sequencing (WGS)-based, tumor-informed circulating tumor DNA (ctDNA) assay, not only for detecting molecular residual disease (MRD), but also for potentially informing adjuvant treatment decisions.

Oncodaily·